🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Two doses each of Hepatitis A Vaccine, Inactivated and Measles, Mumps, Rube...
Status
Completed
Location
Multiple Locations
Start Date
2007-03-26
Trial ID
NCT00326183
This study will evaluate the immunogenicity, safety, and tolerability of VA...
Status
Completed
Location
Alabama Clinical Therapeutics ( Site 0018)
Start Date
2017-10-17
Trial ID
NCT03239873
Treatments Being Tested
This is a study to evaluate the immunogenicity and safety of GlaxoSmithKlin...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-11
Trial ID
NCT00127010
Treatments Being Tested
The purpose of this study is to evaluate end of shelf-life potency in terms...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-10-10
Trial ID
NCT01681992
Treatments Being Tested
This study will look at your body's response to the new immunizations. We w...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2007-07-10
Trial ID
NCT00505063
This study will compare ProQuad™ and concomitant administration of M-M-R™ I...
Status
Terminated
Location
Multiple Locations
Start Date
2008-02
Trial ID
NCT00839917
Primary objectives: * To assess the safety profile of each SP0202 formulat...
Status
Completed
Location
The Children's Clinic Of Jonesboro PA Site Number : 8400143
Start Date
2020-05-22
Trial ID
NCT04398706
Treatments Being Tested
The primary objective of this study is to demonstrate the non-inferiority o...
Status
Completed
Location
Alabama Clinical Therapeutics Site Number : 8400036
Start Date
2018-10-04
Trial ID
NCT03691610
Treatments Being Tested
This study will evaluate the immunogenicity, safety, and tolerability of VA...
Status
Completed
Location
Multiple Locations
Start Date
2014-03-07
Trial ID
NCT02062502
Treatments Being Tested
This is a study to evaluate the immunogenicity and safety of GlaxoSmithKlin...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-05
Trial ID
NCT00127023
Treatments Being Tested